Neurobo Pharmaceuticals Stock Technical Analysis
NRBODelisted Stock | USD 2.36 0.01 0.43% |
As of the 30th of November, Neurobo Pharmaceuticals secures the Standard Deviation of 4.8, risk adjusted performance of (0.07), and Mean Deviation of 3.35. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neurobo Pharmaceuticals, as well as the relationship between them.
Neurobo Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Neurobo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NeuroboNeurobo |
Neurobo Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Neurobo Pharmaceuticals Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Neurobo Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Neurobo Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Neurobo Pharmaceuticals. You can use it to identify possible trend reversals for Neurobo Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Neurobo Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Neurobo Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Neurobo Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Neurobo Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 17.22, which is the sum of squared deviations for the predicted Neurobo Pharmaceuticals price change compared to its average price change.About Neurobo Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Neurobo Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Neurobo Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Neurobo Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Neurobo Pharmaceuticals. By analyzing Neurobo Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Neurobo Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Neurobo Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Neurobo Pharmaceuticals November 30, 2024 Technical Indicators
Most technical analysis of Neurobo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurobo from various momentum indicators to cycle indicators. When you analyze Neurobo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.07) | |||
Market Risk Adjusted Performance | (2.53) | |||
Mean Deviation | 3.35 | |||
Coefficient Of Variation | (1,023) | |||
Standard Deviation | 4.8 | |||
Variance | 23.01 | |||
Information Ratio | (0.13) | |||
Jensen Alpha | (0.50) | |||
Total Risk Alpha | (1.28) | |||
Treynor Ratio | (2.54) | |||
Maximum Drawdown | 25.62 | |||
Value At Risk | (7.34) | |||
Potential Upside | 6.76 | |||
Skewness | 1.47 | |||
Kurtosis | 4.07 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurobo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Neurobo Stock
If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges |